Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Acquisitions & Divestments: 2016-2025

Historic Change in Acquisitions & Divestments for Amphastar Pharmaceuticals (AMPH) over the last 7 years, with Sep 2025 value amounting to $22.5 million.

  • Amphastar Pharmaceuticals' Change in Acquisitions & Divestments rose 327.94% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.3 million, marking a year-over-year decrease of 31.28%. This contributed to the annual value of $126.0 million for FY2024, which is 226.30% up from last year.
  • According to the latest figures from Q3 2025, Amphastar Pharmaceuticals' Change in Acquisitions & Divestments is $22.5 million, which was down 2.20% from $23.0 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $65.8 million for Q2 2024, and its period low was -$179,000 during Q4 2023.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Change in Acquisitions & Divestments value was $14.1 million (recorded in 2023), while the average stood at $21.7 million.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Change in Acquisitions & Divestments slumped by 101.43% in 2023, and later surged by 4,281.01% in 2024.
  • Over the past 5 years, Amphastar Pharmaceuticals' Change in Acquisitions & Divestments (Quarterly) stood at $1.3 million in 2021, then soared by 827.60% to $12.5 million in 2022, then slumped by 101.43% to -$179,000 in 2023, then soared by 4,281.01% to $7.5 million in 2024, then spiked by 327.94% to $22.5 million in 2025.
  • Its last three reported values are $22.5 million in Q3 2025, $23.0 million for Q2 2025, and $28.3 million during Q1 2025.